Sign inGet started

Rombotis Spiro George

Insider CIK 1357396 · CYCC President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CYCC Cyclacel Pharmaceuticals, P Buy deriv2023-12-212023-12-266,070— $06,070SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy2023-12-212023-12-266,070$3.32 $20.2K68,658SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2023-06-302023-07-03110,000— $0110,000SEC↗
CYCC Cyclacel Pharmaceuticals, A Award2023-01-312023-02-0257,600— $062,588SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2021-12-132021-12-15190,000— $0190,000SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2021-12-132021-12-16190,000— $0190,000SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy2021-11-182021-11-224,000$4.50 $18.0K4,988SEC↗
CYCC A Award deriv2020-12-112020-12-15175,000— $0175,000SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2019-12-052019-12-0915,625— $015,625SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2019-12-052019-12-0915,625— $015,625SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2019-01-042019-01-07508,198— $0508,198SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2019-01-032019-01-0715,625— $015,625SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2019-01-032019-01-0714,375— $014,375SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2015-12-072015-12-09437,569— $0437,569SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2015-02-182015-02-2081,742— $081,742SEC↗
CYCC Cyclacel Pharmaceuticals, A Award deriv2013-12-092013-12-10105,000— $0105,000SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy2013-05-212013-05-22100,000$3.00 $300.0K268,292SEC↗
CYCC Cyclacel Pharmaceuticals, P Buy2013-05-212013-05-24100,000$3.00 $300.0K241,416SEC↗
CYCC Cyclacel Pharmaceuticals, A Award2013-01-252013-01-2910,791— $0168,292SEC↗
CYCC Cyclacel Pharmaceuticals, A Award2013-01-252013-01-2920,000— $0157,501SEC↗